Molecular and Cellular Substrates for the Friedreich Ataxia. Significance of Contactin Expression and of Antioxidant Administration.
Animals
Antioxidants
/ administration & dosage
Cell Communication
Cerebellum
/ drug effects
Contactins
/ genetics
Disease Models, Animal
Disease Susceptibility
Friedreich Ataxia
/ genetics
Gene Expression
Humans
Immunohistochemistry
Mice
Mutation
Neuroglia
/ metabolism
Neurons
/ drug effects
Phenotype
Signal Transduction
Spinal Cord
/ drug effects
Friedreich Ataxia
nervous tissue repair
neural cells interactions
neurodegeneration
polyphenols
transmembrane signaling
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
07 Sep 2020
07 Sep 2020
Historique:
received:
29
07
2020
revised:
28
08
2020
accepted:
02
09
2020
entrez:
10
9
2020
pubmed:
11
9
2020
medline:
16
3
2021
Statut:
epublish
Résumé
In this study, the neural phenotype is explored in rodent models of the spinocerebellar disorder known as the Friedreich Ataxia (FA), which results from mutations within the gene encoding the Frataxin mitochondrial protein. For this, the M12 line, bearing a targeted mutation, which disrupts the Frataxin gene exon 4 was used, together with the M02 line, which, in addition, is hemizygous for the human Frataxin gene mutation (Pook transgene), implying the occurrence of 82-190 GAA repeats within its first intron. The mutant mice phenotype was compared to the one of wild type littermates in regions undergoing differential profiles of neurogenesis, including the cerebellar cortex and the spinal cord by using neuronal (β-tubulin) and glial (Glial Fibrillary Acidic Protein) markers as well as the Contactin 1 axonal glycoprotein, involved in neurite growth control. Morphological/morphometric analyses revealed that while in Frataxin mutant mice the neuronal phenotype was significantly counteracted, a glial upregulation occurred at the same time. Furthermore, Contactin 1 downregulation suggested that changes in the underlying gene contributed to the disorder pathogenesis. Therefore, the FA phenotype implies an alteration of the developmental profile of neuronal and glial precursors. Finally, epigallocatechin gallate polyphenol administration counteracted the disorder, indicating protective effects of antioxidant administration.
Identifiants
pubmed: 32906751
pii: molecules25184085
doi: 10.3390/molecules25184085
pmc: PMC7570916
pii:
doi:
Substances chimiques
Antioxidants
0
Contactins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : grant from the Italian Ministry of University and Research (MUR) Rome (Italy)
ID : (code n. XUANR04, NATURE).
Références
Mol Cell Neurosci. 2017 Jun;81:72-83
pubmed: 28064060
J Neurochem. 2013 Aug;126 Suppl 1:53-64
pubmed: 23859341
Prog Neurobiol. 2011 Mar;93(3):421-43
pubmed: 21219963
J Neurol Sci. 2011 Apr 15;303(1-2):1-12
pubmed: 21315377
J Nutr. 2017 Oct;147(10):1926-1931
pubmed: 28835392
Semin Pediatr Neurol. 2003 Sep;10(3):163-72
pubmed: 14653404
Cerebellum. 2020 Feb;19(1):126-130
pubmed: 31701351
J Neurochem. 2013 Aug;126 Suppl 1:65-79
pubmed: 23859342
J Neurol. 2016 Nov;263(11):2215-2223
pubmed: 27522354
Clin Sci (Lond). 2016 Jun 1;130(11):853-70
pubmed: 27129098
Nutr J. 2016 Jun 07;15(1):60
pubmed: 27268025
Oxid Med Cell Longev. 2013;2013:487534
pubmed: 23936609
PLoS One. 2015 Mar 04;10(3):e0116396
pubmed: 25738292
Neural Regen Res. 2019 Feb;14(2):206-216
pubmed: 30530999
Molecules. 2019 Jun 12;24(12):
pubmed: 31212848
J Neurochem. 2013 Aug;126 Suppl 1:88-93
pubmed: 23859344
Mol Ther. 2015 Jan;23(1):130-8
pubmed: 25070719
J Biol Chem. 2019 Feb 22;294(8):2714-2731
pubmed: 30563837
Nat Commun. 2019 May 17;10(1):2210
pubmed: 31101807
Proc Natl Acad Sci U S A. 2014 Jan 21;111(3):E394-403
pubmed: 24385581
Cochrane Database Syst Rev. 2016 Aug 30;(8):CD007791
pubmed: 27572719
Neuroreport. 2017 Jul 5;28(10):590-597
pubmed: 28520620
Semin Neurol. 2014 Jul;34(3):280-92
pubmed: 25192506
Brain Res Bull. 2015 Jan;110:68-75
pubmed: 25522867
Brain Res. 2013 Jun 13;1514:91-7
pubmed: 23587934
Cell. 2010 Mar 19;140(6):918-34
pubmed: 20303880
Neurosci Res. 2018 Jan;126:39-43
pubmed: 29054466
J Cell Biol. 1988 Oct;107(4):1561-73
pubmed: 3049624
Neural Plast. 2016;2016:6427537
pubmed: 27242933
Biochim Biophys Acta. 2016 Mar;1862(3):483-91
pubmed: 26655603
Molecules. 2018 May 29;23(6):
pubmed: 29843466
Front Physiol. 2017 Dec 13;8:1040
pubmed: 29326595
Front Genet. 2014 Jun 03;5:165
pubmed: 24917884
Glia. 2019 Dec;67(12):2248-2263
pubmed: 31328333
Neuromolecular Med. 2016 Sep;18(3):306-21
pubmed: 27147525
J Biochem Mol Toxicol. 2019 Nov;33(11):e22393
pubmed: 31518035
Curr Alzheimer Res. 2019;16(6):529-543
pubmed: 30873922
Hum Mol Genet. 2016 Oct 1;25(19):4288-4301
pubmed: 27516386
Dev Dyn. 2018 Apr;247(4):581-587
pubmed: 29226492
Mol Cell Neurosci. 2017 Jun;81:49-63
pubmed: 27871938
Front Cell Neurosci. 2013 Oct 29;7:196
pubmed: 24194699
Neurochem Res. 2015 Jun;40(6):1211-9
pubmed: 25896296
Arch Neurol. 2008 Oct;65(10):1296-303
pubmed: 18852343
Neurochem Int. 2018 Jul;117:35-48
pubmed: 28782591
Dev Biol. 2012 May 1;365(1):133-51
pubmed: 22360968
Neurosciences (Riyadh). 2017 Jan;22(1):4-13
pubmed: 28064324
Neurobiol Dis. 2019 Dec;132:104606
pubmed: 31494282
PLoS One. 2017 Dec 19;12(12):e0189990
pubmed: 29261783
Adv Exp Med Biol. 2018;1066:223-234
pubmed: 30030829
Physiol Rev. 2014 Oct;94(4):1077-98
pubmed: 25287860
Cell Tissue Res. 2018 Jan;371(1):73-89
pubmed: 28620760
Acta Neuropathol. 2016 Mar;131(3):323-45
pubmed: 26671410
PLoS One. 2014 Sep 08;9(9):e107416
pubmed: 25198290
Br Med Bull. 2017 Dec 1;124(1):19-30
pubmed: 29053830
Front Mol Neurosci. 2018 Nov 20;11:422
pubmed: 30515076
Cell. 2003 Oct 17;115(2):163-75
pubmed: 14567914
J Vet Med Sci. 2020 May 20;82(5):639-645
pubmed: 32224555
Cereb Cortex. 2019 Feb 1;29(2):586-597
pubmed: 29300891
World J Cardiol. 2019 Jan 26;11(1):1-12
pubmed: 30705738
Handb Clin Neurol. 2018;154:129-149
pubmed: 29903436
Neural Plast. 2017;2017:8081758
pubmed: 28331639
Acta Neuropathol. 2010 Jul;120(1):97-108
pubmed: 20339857
Mol Cell Neurosci. 2017 Apr;80:100-110
pubmed: 28286293
Clin Biochem. 2017 Dec;50(18):1061-1066
pubmed: 28860054
Am J Hum Genet. 2008 Dec;83(6):714-24
pubmed: 19026398
J Cell Biol. 1989 Aug;109(2):775-88
pubmed: 2474555
Neurotherapeutics. 2019 Oct;16(4):1032-1049
pubmed: 31317428
Neuron. 1991 Apr;6(4):595-606
pubmed: 2015094
J Neurol Neurosurg Psychiatry. 2018 Jan;89(1):61-71
pubmed: 28819062
Dis Model Mech. 2015 Mar;8(3):225-35
pubmed: 25681319
Adv Exp Med Biol. 2018;1049:233-241
pubmed: 29427106
Glia. 2018 Mar;66(3):576-591
pubmed: 29165835
Front Cell Neurosci. 2016 Sep 26;10:215
pubmed: 27725795
Antioxidants (Basel). 2019 Dec 31;9(1):
pubmed: 31906123
J Comp Neurol. 1999 Oct 25;413(3):357-72
pubmed: 10502245
Neuroscience. 2020 Jan 1;424:182-183
pubmed: 31682946
Neural Regen Res. 2017 Sep;12(9):1551-1558
pubmed: 29090003
J Neurol Sci. 2005 Jun 15;233(1-2):145-62
pubmed: 15896810
Genet Med. 2013 Sep;15(9):673-83
pubmed: 23538602
Front Immunol. 2017 Jun 09;8:677
pubmed: 28649251
Stem Cells Dev. 2020 Mar 1;29(5):266-280
pubmed: 31847709
Oxid Med Cell Longev. 2012;2012:914273
pubmed: 22701758
Curr Drug Targets. 2018;19(8):927-937
pubmed: 28356027
Mol Neurobiol. 2017 Jul;54(5):3652-3664
pubmed: 27206430
FEBS Lett. 2018 Mar;592(5):718-727
pubmed: 29197070
Handb Clin Neurol. 2018;155:191-203
pubmed: 29891058
Free Radic Biol Med. 2016 Nov;100:138-146
pubmed: 27296838
Brain. 2016 Jun;139(Pt 6):1700-12
pubmed: 27017186
J Neurochem. 2013 Aug;126 Suppl 1:43-52
pubmed: 23859340
Front Cell Dev Biol. 2019 Jul 18;7:119
pubmed: 31380366
Life Sci. 2016 Sep 15;161:69-77
pubmed: 27493077
Neurodegener Dis Manag. 2016;6(1):49-65
pubmed: 26782317
Expert Rev Neurother. 2017 Sep;17(9):895-907
pubmed: 28724340
Trends Pharmacol Sci. 2019 Apr;40(4):229-233
pubmed: 30905359
Trends Neurosci. 2015 Jun;38(6):364-74
pubmed: 25975510
Handb Clin Neurol. 2013;113:1869-78
pubmed: 23622410
J Neurosci. 2004 Feb 25;24(8):1987-95
pubmed: 14985441
Trends Cardiovasc Med. 2017 Jan;27(1):51-58
pubmed: 27452966
J Neuropathol Exp Neurol. 2017 Feb 1;76(2):101-108
pubmed: 28082326
Curr Pharm Des. 2012;18(1):43-50
pubmed: 22211687
Muscle Nerve. 2005 Jun;31(6):780-7
pubmed: 15818635
J Neuropathol Exp Neurol. 2009 Nov;68(11):1207-18
pubmed: 19816196
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Adv Exp Med Biol. 2019;1173:125-143
pubmed: 31456208
Mol Neurobiol. 2017 Dec;54(10):7908-7916
pubmed: 27864734
Neurosci Biobehav Rev. 2018 Jan;84:394-406
pubmed: 28823857
J Neurochem. 2013 Aug;126 Suppl 1:103-17
pubmed: 23859346
J Neurol. 2009 Mar;256 Suppl 1:9-17
pubmed: 19283345